Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$0.75 - $1.31 $3,415 - $5,965
-4,554 Reduced 15.69%
24,470 $30,000
Q1 2024

May 20, 2024

BUY
$0.79 - $1.14 $4,580 - $6,609
5,798 Added 24.96%
29,024 $28,000
Q4 2023

Feb 26, 2024

BUY
$1.02 - $2.57 $23,690 - $59,690
23,226 New
23,226 $25,000
Q3 2022

Nov 07, 2022

BUY
$2.13 - $4.0 $34,774 - $65,304
16,326 New
16,326 $37,000
Q4 2021

Feb 17, 2022

SELL
$0.86 - $2.3 $57,413 - $153,548
-66,760 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$0.89 - $1.55 $59,416 - $103,478
66,760 New
66,760 $60,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $41.9M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.